A protein in muscle may play a role in type 2 diabetes

Miro1 accumulation in skeletal muscle is linked to insulin resistance in patients with obesity and type 2 diabetes.

Miro1 accumulation in skeletal muscle is linked to type 2 diabetes (T2D). This protein is an outer mitochondrial membrane enzyme.

Researchers studied Miro1 in patients with obesity and T2D. They also used mouse models of T2D to replicate these findings.

The accumulation happens because insulin-mediated interaction between AKT and Miro1 at the outer mitochondrial membrane is inadequate. Mitochondrial dynamics involve the movement and balance of mitochondria.

A randomized controlled trial (NCT02977442) showed that exercise training relieves Miro1 accumulation. This training also improves insulin sensitivity in patients with T2D.

Deleting Miro1 specifically in muscle improves oxidative capacity and insulin sensitivity in cells and mice. These data support a key regulatory role for Miro1 in the pathophysiology of T2D.

Key facts

  • Miro1 accumulates in the skeletal muscle of patients with obesity and T2D.
  • Exercise training relieves Miro1 accumulation and improves insulin sensitivity in T2D patients.
  • Muscle-specific Miro1 deletion improves oxidative capacity and insulin sensitivity in mice and cells.

All sections

Edition